Exploring the Cortical Hemodynamic Response of Excitatory Brain Stimulation: a Pilot Study
Intermittent theta-burst stimulation (iTBS) is a promising treatment for major depressive disorder. However, fewer than 50% of patients show sufficient response. Therefore, the optimal treatment protocol is worth investigating. Recent studies show that the relationship between stimulation intensity and prefrontal hemodynamic response is not linear but in an inverse U-shape by exploring the hemodynamic changes before and after iTBS. Concurrent transcranial magnetic stimulation (TMS)/functional near-infrared spectroscopy (fNIRS) setup allows the investigators to observe the prefrontal hemodynamic response during stimulation.
The aim of this study is to investigate the effects of different intensities on brain activity during and after the stimulation using fNIRS.
研究概览
详细说明
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Hong Kong、香港
- The Hong Kong Polytechnic University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Right-handed
Exclusion Criteria:
- history of epilepsy, seizures, or convulsions
- current or past diagnosis of neurological disorders, such as head injuries, strokes, encephalitis, epilepsy, Parkinson's, or Alzheimer's
- current or past diagnosis of psychiatric disorders, such as depression, anxiety, schizophrenia, or autism
- with metal implants, such as a cochlear implant, neurostimulator, or cardiac pacemaker
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Prefrontal hemodynamic response to 50% rMT iTBS
Participants will receive 50% rMT iTBS over left DLPFC in this arm.
The prefrontal hemodynamic response will be observed simultaneously before, during, and after iTBS using fNIRS.
|
The iTBS will be applied over lDLPFC with three different intensities.
The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007.
The equation is AdjMT% = MT + 2.8 * (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8*6=16.8(%)
were added to the normal intensity.
其他名称:
|
|
实验性的:Prefrontal hemodynamic response to 70% rMT iTBS
Participants will receive 70% rMT iTBS over left DLPFC in this arm.
The prefrontal hemodynamic response will be observed simultaneously before, during, and after iTBS using fNIRS.
|
The iTBS will be applied over lDLPFC with three different intensities.
The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007.
The equation is AdjMT% = MT + 2.8 * (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8*6=16.8(%)
were added to the normal intensity.
其他名称:
|
|
实验性的:Prefrontal hemodynamic response to 90% rMT iTBS
Participants will receive 90% rMT iTBS over left DLPFC in this arm.
The prefrontal hemodynamic response will be observed simultaneously before, during, and after iTBS using fNIRS.
|
The iTBS will be applied over lDLPFC with three different intensities.
The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007.
The equation is AdjMT% = MT + 2.8 * (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8*6=16.8(%)
were added to the normal intensity.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
与基线相比,氧合血红蛋白 (HbO) 发生变化
大体时间:TBS-fNIRS 测量期间和之后,最长 3 个月
|
iTBS 刺激前、刺激期间和刺激后 DLPFC 中 HbO 的变化
|
TBS-fNIRS 测量期间和之后,最长 3 个月
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Deoxygenated hemoglobin (HbR) Change compared to baseline
大体时间:During and post TBS-fNIRS measurement, up to 3 months
|
iTBS-induced HbR change in the DLPFC before, during and after stimulation
|
During and post TBS-fNIRS measurement, up to 3 months
|
|
与基线相比的氧饱和度变化
大体时间:TBS-fNIRS 测量期间和之后,最长 3 个月
|
iTBS 在刺激之前、期间和之后引起的 DLPFC 氧饱和度变化
|
TBS-fNIRS 测量期间和之后,最长 3 个月
|
合作者和调查者
调查人员
- 首席研究员:Georg S Kranz, PhD、The Hong Kong Polytechnic University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- HSEARS20200120005-01
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.